Eerenberg-Belmer AJ - Search Results

1

Polyethylene glycol enhances the binding of C1q to circulating immune complexes.

Hack CE, Eerenberg-Belmer AJ, Hannema AJ, Out TA, Aalberse RC. Hack CE, et al. J Immunol Methods. 1981;44(2):211-21. doi: 10.1016/0022-1759(81)90349-5. J Immunol Methods. 1981. PMID: 6792284

2

Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.

Hack CE, Eerenberg-Belmer AJ, Lim UG, Haverman J, Aalberse RC. Hack CE, et al. Arthritis Rheum. 1984 Jan;27(1):40-8. doi: 10.1002/art.1780270108. Arthritis Rheum. 1984. PMID: 6318777

3

SLE like syndrome and functional deficiency of C1q in members of a large family.

Hannema AJ, Kluin-Nelemans JC, Hack CE, Eerenberg-Belmer AJ, Mallée C, van Helden HP. Hannema AJ, et al. Clin Exp Immunol. 1984 Jan;55(1):106-14. Clin Exp Immunol. 1984. PMID: 6319055 Free PMC article.

4

A C1-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo.

Hack CE, Hannema AJ, Eerenberg-Belmer AJ, Out TA, Aalberse RC. Hack CE, et al. J Immunol. 1981 Oct;127(4):1450-3. J Immunol. 1981. PMID: 6168693

5

Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor).

Nuijens JH, Huijbregts CC, Eerenberg-Belmer AJ, Meijers JC, Bouma BN, Hack CE. Nuijens JH, et al. Among authors: eerenberg belmer aj. J Biol Chem. 1989 Aug 5;264(22):12941-9. J Biol Chem. 1989. PMID: 2473984 Free article.

6

Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis.

Nuijens JH, Huijbregts CC, Eerenberg-Belmer AJ, Abbink JJ, Strack van Schijndel RJ, Felt-Bersma RJ, Thijs LG, Hack CE. Nuijens JH, et al. Blood. 1988 Dec;72(6):1841-8. Blood. 1988. PMID: 3264190 Free article.

7

A progress report of a phase I study of interferon-gamma and interleukin-2 and some comments on the mechanism of the toxicity due to interleukin-2.

Wagstaff J, Vermorken JB, Schwartsmann G, Scheper RJ, Hack CE, Nuijens JH, Eerenberg-Belmer AJ, Pinedo HM. Wagstaff J, et al. Cancer Treat Rev. 1989 Jun;16 Suppl A:105-9. doi: 10.1016/0305-7372(89)90029-7. Cancer Treat Rev. 1989. PMID: 2504491 No abstract available.

8

Angioneurotic oedema and urticaria during therapy with interleukin-2 (IL-2).

Baars JW, Wagstaff J, Hack CE, Wolbink GJ, Eerenberg-Belmer AJ, Pinedo HM. Baars JW, et al. Among authors: eerenberg belmer aj. Ann Oncol. 1992 Mar;3(3):243-4. doi: 10.1093/oxfordjournals.annonc.a058162. Ann Oncol. 1992. PMID: 1586626 Free article. No abstract available.

9

Complement activation and high-dose of interleukin-2.

Thijs LG, Hack CE, Strack van Schijndel RJ, Nuijens JH, Wolbink GJ, Eerenberg-Belmer AJ, van der Vall H, Wagstaff J. Thijs LG, et al. Among authors: eerenberg belmer aj. Lancet. 1989 Aug 12;2(8659):395. doi: 10.1016/s0140-6736(89)90577-1. Lancet. 1989. PMID: 2569587 No abstract available.

10

Increased plasma levels of interleukin-6 in sepsis.

Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA. Hack CE, et al. Among authors: eerenberg belmer aj. Blood. 1989 Oct;74(5):1704-10. Blood. 1989. PMID: 2790194 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page